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During organ transplantation, graft endothelium is the first barrier encountered by
immune cells of the recipient. Endothelial cells surface presents inflammatory and
immune proteins which are over-expressed after activation by pro-inflammatory
cytokines, Damage Associated Molecular Patterns (DAMPs) or Advanced Glycation
End Products (AGEs) [1]. Among natural products, several polyprenylated
polyphenols have shown anti-inflammatory, immunomodulatory and anti-AGEs
properties [2 – 3]. Such secondary metabolites are biosynthesized by Calophyllaceae
species such as Calophyllum or Mesua species. In order to identify natural products
able to prevent endothelial dysfunction, a dereplication analysis was conducted on
various extracts from Calophyllum and Mesua species native to Malaysia. It
appeared that the fruits of Mesua lepidota T. Anderson are a rich source of original
phenylcoumarins named as lepidotols and lepidotins. The main compound, lepidotol
A, was evaluated for its anti-inflammatory, immunomodulatory and anti-AGEs
potential. Beside a potent inhibitory effect of the VCAM-1, class II HLA and HLA-E
induced surface-expressions on human endothelial cells (52%, 97% and 66%,
respectively), lepidotol A exhibited an inhibition of AGEs formation five to thirty
times higher than aminoguanidine (positive control). These results are consistent
with the marked pharmacological activities of prenylated aromatic metabolites [4],
and highlight a new approach to discover protective compounds against graft
rejection.
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